RegenVOX: a Phase I/II clinical trial of stem cell-based tissue-engineered laryngeal implantsMartin Birchall, Mark W. Lowdell, Susan Tebbs et al.|Cytotherapy|2015Cited by 1
452. RegenVOX - Translational Exploitation Strategy for Stem Cell-Based Tissue-Engineered Laryngeal Implants Undergoing Phase I/II Clinical TrialEmily J Culme-Seymour, Chris Mason, Carla Carvalho et al.|Molecular Therapy|2016Cited by 0